August 3, 2026 · JAMA · DOI: 10.1001/jama.2026.13402

Classic Hodgkin Lymphoma: A Review

Listen to this summary

This review aims to provide a comprehensive overview of classic Hodgkin lymphoma (cHL), including its epidemiology, clinical presentation, risk factors, and treatment strategies. The authors highlight that cHL primarily affects younger individuals and that first-line treatment typically involves chemotherapy, with potential additions of radiotherapy and novel agents for certain patient groups. They also discuss the long-term risks faced by survivors, emphasizing the importance of monitoring for secondary malignancies and other complications.

Kishan K Patel, Alison J Moskowitz

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play